A new trading day began on Friday, with Replimune Group Inc (NASDAQ: REPL) stock price up 6.21% from the previous day of trading, before settling in for the closing price of $6.92. REPL’s price has ranged from $4.92 to $17.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 11.67%. With a float of $61.80 million, this company’s outstanding shares have now reached $77.01 million.
The extent of productivity of a business whose workforce counts for 331 workers is very important to gauge. In terms of profitability, gross margin is 65.59%, operating margin of -5963.83%, and the pretax margin is -5634.14%.
Replimune Group Inc (REPL) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Replimune Group Inc is 19.76%, while institutional ownership is 88.69%. The most recent insider transaction that took place on Dec 16 ’24, was worth 124,200. In this transaction Chief Executive Officer of this company sold 10,000 shares at a rate of $12.42, taking the stock ownership to the 202,014 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Chief Strategy Officer proposed sale 15,000 for $12.57, making the entire transaction worth $188,550.
Replimune Group Inc (REPL) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.91% during the next five years compared to -19.52% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Here are Replimune Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.14, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.74 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
The latest stats from [Replimune Group Inc, REPL] show that its last 5-days average volume of 1.05 million was superior to 0.77 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 20.59%. Additionally, its Average True Range was 0.80.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 8.62%, which indicates a significant decrease from 19.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.97% in the past 14 days, which was lower than the 81.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.60, while its 200-day Moving Average is $11.33. Now, the first resistance to watch is $7.51. This is followed by the second major resistance level at $7.68. The third major resistance level sits at $7.99. If the price goes on to break the first support level at $7.03, it is likely to go to the next support level at $6.72. Assuming the price breaks the second support level, the third support level stands at $6.55.
Replimune Group Inc (NASDAQ: REPL) Key Stats
With a market capitalization of 566.02 million, the company has a total of 77,015K Shares Outstanding. Currently, annual sales are 0 K while annual income is -215,790 K. The company’s previous quarter sales were 0 K while its latest quarter income was -66,340 K.
